HealthcareJul 16, 2026

FinVector Vision Therapies

Company Profile Analysis

Book Demo Subscribe Now

FinVector Vision Therapies - Healthcare showcase

Year Founded & Workforce

1996-12-31

100 Employees

Industry

Healthcare

Services

FinVector Vision Therapies Overview

Company Headquarters: Kuopio, Finland

Founded: 1997

Workforce: 100+

Company Working:

FinVector Vision Therapies was previously known as Ark Therapeutics Limited and it is a major player in the market which is involved in research and development of viral-based gene therapy products. The company develops and manufactures products used for gene therapy through its manufacturing facility which is approved by European Medicines Agency(EMA). It offers services and viral-based product types, including Adenoviral, AAV, and Lentiviral-based vectors. The company operates in business segments namely, cell banking and viral seed stocks, R&D cell/gene therapy unit, platform process development / scale up, assay development and analytical testing, cGMP Manufacturing capabilities, FinVector aseptic filling capability, stability studies, Viral Vectors (including Adeno, AAV, Lenti), and Others.

Company Snapshot

100

Employees

1996-12-31

Founded

Kuopio, Finland

Headquarters

A plan for every need

Forecast+

Get unlimited access to forecasts, charts, and company data across every research report on Wantstats.

USD200/mo

About the Author

Wantstats Research Team

Wantstats' research desk profiles FinVector Vision Therapies as part of our ongoing coverage of the Healthcare sector, drawing on public company data, filings, and market intelligence.

Powering the world's best teams.
From next-gen startups to established enterprises.

See our work in action

Start your data driven journey with us!

Book a Demo Now

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

FinVector Vision Therapies

Company Headquarters: Kuopio, Finland Founded: 1997 Workforce: 100+ Company Working: FinVector Vision Therapies was previously known as Ark Therapeutics Limited and it is a major player in the market which is involved in research and development of viral-based gene therapy products. The company develops and manufactures products used for gene therapy through its manufacturing facility which is approved by European Medicines Agency(EMA). It offers services and viral-based product types, including Adenoviral, AAV, and Lentiviral-based vectors. The company operates in business segments namely, cell banking and viral seed stocks, R&D cell/gene therapy unit, platform process development / scale up, assay development and analytical testing, cGMP Manufacturing capabilities, FinVector aseptic filling capability, stability studies, Viral Vectors (including Adeno, AAV, Lenti), and Others.

Starting from

$4,950